Willem Flameng
Corporate Officer/Principal chez Katholieke Universiteit Leuven
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Geofrey de Visscher | M | - |
Anethon NV
 Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD.
Katholieke Universiteit Leuven
| 23 ans |
| Herman Daems | M | 78 |
Katholieke Universiteit Leuven
| 12 ans |
| Koenraad Debackere | M | 63 |
Katholieke Universiteit Leuven
| - |
| Pol Bamelis | M | 85 |
Katholieke Universiteit Leuven
| - |
| Marleen Willekens | M | 58 |
Katholieke Universiteit Leuven
| 29 ans |
| Liesbet van der Perre | M | 55 |
Katholieke Universiteit Leuven
| - |
| Hilde Laga | M | 68 |
Katholieke Universiteit Leuven
| - |
| Giorgio Basevi | M | 85 |
Katholieke Universiteit Leuven
| - |
| Jos van der Sloten | M | 61 |
Katholieke Universiteit Leuven
| 18 ans |
| Koen Geens | M | 66 |
Katholieke Universiteit Leuven
| - |
| Jules Stuyck | M | 76 |
Katholieke Universiteit Leuven
| - |
| Michiel S. J. Steyaert | M | - |
Katholieke Universiteit Leuven
| - |
| Jan Smets | M | 73 |
Katholieke Universiteit Leuven
| - |
| Katrien Kesteloot | F | 61 |
Katholieke Universiteit Leuven
| - |
| André Oosterlinck | M | 78 |
Katholieke Universiteit Leuven
| - |
| Dirk Heremans | M | 81 |
Katholieke Universiteit Leuven
| - |
| Cynthia van Hulle | M | 68 |
Katholieke Universiteit Leuven
| - |
| Filip Roodhooft | M | - |
Katholieke Universiteit Leuven
| - |
| Koen van Gerven | M | 65 |
Katholieke Universiteit Leuven
| - |
| Johan Hendrik Neyts | M | - |
Katholieke Universiteit Leuven
| - |
| Fred van Leuven | M | - |
Katholieke Universiteit Leuven
| - |
| Bart de Moor | M | 63 |
Katholieke Universiteit Leuven
| - |
| Luc Jacques Bertrand | M | 73 |
Katholieke Universiteit Leuven
| - |
| Bart Boesmans | M | 60 |
Katholieke Universiteit Leuven
| 10 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Els Vanheusden | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
| Frank Bulens | M | 61 |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
| Paul van Dun | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
| Jaak Minten | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
| Annie van Broeckhoven | M | - |
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Belgique | 29 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Willem Flameng
- Réseau Personnel
